Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Passive and oxymetazoline-enhanced delivery with a lens device: pharmacokinetics and efficacy studies with rabbits.

Miller DJ, Li SK, Tuitupou AL, Kochambilli RP, Papangkorn K, Mix DC Jr, Higuchi WI, Higuchi JW.

J Ocul Pharmacol Ther. 2008 Aug;24(4):385-91. doi: 10.1089/jop.2007.0116.

2.

A study of the dexamethasone sodium phosphate release properties from a periocular capsular drug delivery system.

Huang Z, Yang W, Zong Y, Qiu S, Chen X, Sun X, Zhou Y, Xie Z, Gao Q.

Drug Deliv. 2016;23(3):849-57. doi: 10.3109/10717544.2014.919543. Epub 2014 May 28.

PMID:
24865291
3.

Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation.

Kesavan K, Kant S, Singh PN, Pandit JK.

Curr Eye Res. 2013 Mar;38(3):342-52. doi: 10.3109/02713683.2012.745879. Epub 2012 Dec 7.

PMID:
23216079
4.
5.

Sustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous body.

Liu Y, Ke Q, Chen J, Wang Z, Xie Z, Jiang Z, Ge J, Gao Q.

Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1636-42. doi: 10.1167/iovs.09-4134. Epub 2009 Oct 15.

PMID:
19834025
6.

Trans-scleral iontophoretic delivery of low molecular weight therapeutics.

Güngör S, Delgado-Charro MB, Ruiz-Perez B, Schubert W, Isom P, Moslemy P, Patane MA, Guy RH.

J Control Release. 2010 Oct 15;147(2):225-31. doi: 10.1016/j.jconrel.2010.07.107. Epub 2010 Jul 23.

PMID:
20655965
7.

Laser-induced intrachoroidal dexamethasone drug delivery system to posterior eye segment.

Murata M, Sanbe A, Lee JW, Nishigori H.

Invest Ophthalmol Vis Sci. 2013 Dec 19;54(13):8317-24. doi: 10.1167/iovs.13-13078.

PMID:
24265021
8.

Controllable continuous sub-tenon drug delivery of dexamethasone disodium phosphate to ocular posterior segment in rabbit.

Huang X, Liu S, Yang Y, Duan Y, Lin D.

Drug Deliv. 2017 Nov;24(1):452-458. doi: 10.1080/10717544.2016.1264498.

PMID:
28165816
9.

Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.

Sakurai E, Nozaki M, Okabe K, Kunou N, Kimura H, Ogura Y.

Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4845-52.

PMID:
14578407
10.

Pharmacokinetics and efficacy of Bioerodible Dexamethasone implant in Concanavalin A-induced uveitic cataract rabbit model.

Chennamaneni SR, Bohner A, Bernhisel A, Ambati BK.

Pharm Res. 2014 Nov;31(11):3179-90. doi: 10.1007/s11095-014-1410-7. Epub 2014 Jun 20.

PMID:
24947436
11.

Electro-responsive macroporous polypyrrole scaffolds for triggered dexamethasone delivery.

Seyfoddin A, Chan A, Chen WT, Rupenthal ID, Waterhouse GI, Svirskis D.

Eur J Pharm Biopharm. 2015 Aug;94:419-26. doi: 10.1016/j.ejpb.2015.06.018. Epub 2015 Jun 30.

PMID:
26141345
12.

Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.

Cheng CK, Berger AS, Pearson PA, Ashton P, Jaffe GJ.

Invest Ophthalmol Vis Sci. 1995 Feb;36(2):442-53.

PMID:
7843913
13.

Contact lenses as a drug delivery device for epidermal growth factor in the treatment of ocular wounds.

Schultz CL, Morck DW.

Clin Exp Optom. 2010 Mar;93(2):61-5. doi: 10.1111/j.1444-0938.2010.00459.x.

14.

Metabolic changes in rabbit lens induced by treatment with dexamethasone.

Pescosolido N, Miccheli A, Manetti C, Iannetti GD, Feher J, Cavallotti C.

Ophthalmic Res. 2001 Mar-Apr;33(2):68-74.

PMID:
11244350
15.

Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate.

Kunou N, Ogura Y, Honda Y, Hyon SH, Ikada Y.

J Biomed Mater Res. 2000 Sep 15;51(4):635-41.

PMID:
10880111
16.

Decreased rhinovirus shedding after intranasal oxymetazoline application in adults with induced colds compared with intranasal saline.

Winther B, Buchert D, Turner RB, Hendley JO, Tschaikin M.

Am J Rhinol Allergy. 2010 Sep-Oct;24(5):374-7. doi: 10.2500/ajra.2010.24.3491.

PMID:
21244738
17.

Detection of dexamethasone in the cornea and lens by NMR spectroscopy.

Midelfart A, Dybdahl A, Krane J.

Graefes Arch Clin Exp Ophthalmol. 1999 May;237(5):415-23.

PMID:
10333109
18.

Evaluation of a delivery system providing long-term release of cyclosporine.

Pearson PA, Jaffe GJ, Martin DF, Cordahi GJ, Grossniklaus H, Schmeisser ET, Ashton P.

Arch Ophthalmol. 1996 Mar;114(3):311-7.

PMID:
8600892
19.

An intravitreal device providing sustained release of cyclosporine and dexamethasone.

Enyedi LB, Pearson PA, Ashton P, Jaffe GJ.

Curr Eye Res. 1996 May;15(5):549-57.

PMID:
8670756
20.

Anti-rhinovirus-specific activity of the alpha-sympathomimetic oxymetazoline.

Koelsch S, Tschaikin M, Sacher F.

Arzneimittelforschung. 2007;57(7):475-82.

PMID:
17803062

Supplemental Content

Support Center